The obesity doctor gives his take on a joke about GLP-1 drugs. A quick, light clip with few details given.
Recap by typeshit. Post by @drnadolsky on Instagram.
The Darling Ingredients unit says the supplement ingredient concentrates over ten neurosupportive peptides, with clinical trials planned to start in December.
The plastic surgeon weighs in on semaglutide and other GLP-1 drugs as more patients of every age turn to them for major weight loss.
Toby notes Lilly posted $22.97 billion in Q2 2026 revenue, up 46% in a year, driven by one molecule sold under two brand names.
Traders Union looks at whether Novo Nordisk shares can hold their gains, pointing to the Wegovy pill approval and recent trial data.
Analytical chemists explain how sample prep can create or hide impurities in GLP-1 drugs, and why methionine oxidation hurts reproducibility.
The Dermatology Digest covers a study pairing the psoriasis biologic with tirzepatide, reporting bigger biomarker shifts from the combination.
Loading…